| Circulating mitochondrial DNA in serum: a universal diagnostic biomarker for patients with urological malignancies J Ellinger, DC Müller, SC Müller, S Hauser, LC Heukamp, A von Ruecker, ... Urologic oncology: seminars and original investigations 30 (4), 509-515, 2012 | 124 | 2012 |
| Prostate cancer patient‐derived organoids: detailed outcome from a prospective cohort of 81 clinical specimens R Servant, M Garioni, T Vlajnic, M Blind, H Pueschel, DC Müller, ... The Journal of pathology 254 (5), 543-555, 2021 | 44 | 2021 |
| Comprehensive molecular characterization of urothelial bladder carcinoma: a step closer to clinical translation CA Rentsch, DC Müller, C Ruiz, L Bubendorf Eur Urol 72 (6), 960-961, 2017 | 44 | 2017 |
| Donor‐derived, metastatic urothelial cancer after kidney transplantation associated with a potentially oncogenic BK polyomavirus DC Müller, M Rämö, K Naegele, S Ribi, C Wetterauer, V Perrina, ... The Journal of Pathology 244 (3), 265-270, 2018 | 37 | 2018 |
| Delineation of human prostate cancer evolution identifies chromothripsis as a polyclonal event and FKBP4 as a potential driver of castration resistance JR Federer‐Gsponer, C Quintavalle, DC Mueller, T Dietsche, V Perrina, ... The Journal of pathology 245 (1), 74-84, 2018 | 26 | 2018 |
| Patterns of stemness‐associated markers in the development of castration‐resistant prostate cancer JR Federer‐Gsponer, DC Müller, T Zellweger, M Eggimann, K Marston, ... The Prostate 80 (13), 1108-1117, 2020 | 20 | 2020 |
| Immunocytochemistry for ARID1A as a potential biomarker in urine cytology of bladder cancer SG Dugas, DC Müller, C Le Magnen, J Federer‐Gsponer, HH Seifert, ... Cancer Cytopathology 127 (9), 578-585, 2019 | 17 | 2019 |
| Exploring the spatiotemporal genetic heterogeneity in metastatic lung adenocarcinoma using a nuclei flow‐sorting approach T Lorber, N Andor, T Dietsche, V Perrina, D Juskevicius, K Pereira, ... The Journal of Pathology 247 (2), 199-213, 2019 | 9 | 2019 |
| Somatic Features of Response and Relapse in Non–muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guérin Immunotherapy JVW Bacon, DC Müller, E Ritch, M Annala, SG Dugas, C Herberts, ... European Urology Oncology, 2021 | 8 | 2021 |
| Biology of BCG response in non-muscle invasive bladder cancer-2021 IBCN Updates Part III MJ Reike, MA Ingersoll, DC Müller, TCM Zuiverloon, T Strandgaard, ... Urologic Oncology: Seminars and Original Investigations, 2022 | 4 | 2022 |
| Genomic evolutionary trajectory of metastatic squamous cell carcinoma of the lung A Krause, L Roma, T Lorber, T Dietsche, V Perrina, DC Müller, ... Translational lung cancer research 10 (4), 1792, 2021 | 4 | 2021 |
| Moving Towards Minimally Invasive Genomically Based Diagnosis and Monitoring of Bladder Cancer. CA Rentsch, DC Müller, C Ruiz, L Bubendorf European Urology 70 (1), 83-84, 2016 | 3 | 2016 |
| Exploring the intratumoral heterogeneity of DNA ploidy in prostate cancer T Vlajnic, DC Müller, C Ruiz, R Schönegg, HH Seifert, GN Thalmann, ... Cancer Reports, e1953, 2023 | | 2023 |
| Development of novel prostate cancer patient-derived models and applications for translational research R Servant, M Garioni, T Vlajnic, H Pueschel, DC Müller, T Zellweger, ... European Urology Open Science 32, S173, 2021 | | 2021 |
| Pathomechanisms of disease-progression in urothelial and prostate cancer DC Müller University_of_Basel, 2021 | | 2021 |
